Sort
64,565 grants matching “drug discovery”
Dissecting splicing factor mutations in iPSCs
$828,077Eirini Papapetrou · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · HL
Center for Applied Preclinical Research (CAPR)
$828,050Terry Van Dyke · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA
Harnessing Diverse BioInformatic Approaches to Repurpose Drugs for Alzheimers Disease
$828,046Mark W Albers · Massachusetts General Hospital · R01 · FY2018 · AG
Identification of Common Genetic Variants for Atrial Fibrillation and PR Interval
$827,989Patrick Thomas Ellinor · Massachusetts General Hospital · R01 · FY2017 · HL
Intranasal delivery of VGF-derived peptides in a preclinical model of Alzheimer's disease
$827,826Stephen R Salton · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AG
Biological Comparisons Among Three Derivative Models of Glioma Patient Cancers Under Microenvironmental Stress
$827,700Christopher D Willey · University Of Alabama At Birmingham · U01 · FY2020 · CA
Imaging epigenetic dysregulation in the Lewy body dementias with [11C]Martinostat
$827,629Stephen N. Gomperts · Massachusetts General Hospital · R01 · FY2024 · AG
Disease-Specific Integrated Microphysiological Human Tissue Models
$827,522Kevin E Healy · University Of California Berkeley · UH3 · FY2015 · TR
Centenarian Consortium Project
$827,496Thomas T Perls · California Pacific Med Ctr Res Institute · U19 · FY2019 · AG
Discovery of Natural Products and Natural Product-Like Inhibitors
$827,493Carole Bewley · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2011 · DK
Discovery of Addiction-Related Genes with Advanced Mouse Resources
$827,371Elissa J Chesler · Jackson Laboratory · R01 · FY2022 · DA
Mid Southern Primary Care Networks Node
$827,206Li-Tzy T Wu · Duke University · UG1 · FY2015 · DA
Signal Transduction Events and the Regulation of Cell Growth
$827,195Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2011 · CA
Function interactions between mitogen-activated protein kinases (MAPKs) and SARS-CoV-2
$827,164Jeffrey R Johnson · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AI
Genome wide assessment of essential genes in Trypanosoma brucei
$827,156Kenneth D Stuart · Seattle Biomedical Research Institute · R01 · FY2011 · AI
Ikaros family genes and lupus susceptibility across ethnically diverse populations
$827,115Swapan K Nath · Oklahoma Medical Research Foundation · R01 · FY2019 · AI
Discovery of natural product-based drugs from Costa Ric*
$826,974Jon Clardy · Harvard Medical School · U01 · FY2006 · TW
Genetics of novelty seeking and propensity for drug abuse in outbred rats
$826,942Huda Akil · University Of Michigan At Ann Arbor · U01 · FY2024 · DA
Pharmacology & human Phase 1 safety & dose escalation studies using anti-GP88 in aggressive breast cancer
$826,939Ginette Serrero · A And G Pharmaceutical, Inc. · R44 · FY2022 · CA
UMGCC Paul Calabresi Clinical Oncology Training Program
$826,874Edward A Sausville · University Of Maryland Baltimore · K12 · FY2013 · CA
Discovery and development of broad spectrum anti-flaviviral drugs
$826,847Timothy A Haystead · Duke University · R01 · FY2014 · AI
Functional high-throughput contractility assay suite to develop therapeutics for asthma andhypertension
$826,810Ivan Pushkarsky · Forcyte Biotechnologies, Inc. · R44 · FY2019 · TR
Interdepartmental Biotechnology Training Program
$826,768Karl D Wittrup · Massachusetts Institute Of Technology · T32 · FY2009 · GM
Large-scale Genetic Investigation and Drug Discovery to Counteract Down Syndrome Neural Deficits
$826,661Summer B Thyme · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · HD
EHR-based Genomic Discovery and Implementation
$826,601Iftikhar J Kullo · Mayo Clinic Rochester · U01 · FY2019 · HG